[{"address1": "2 Corporate Drive", "address2": "First Floor", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 239 2030", "website": "https://www.sentibio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Senti Biosciences, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. Its lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. The company's product candidates also include SENTI-202, a logic gated off-the-shelf CAR-NK cell therapy for the treatment of blood cancers and relapsed/refractory hematological malignancies, including acute myeloid leukemia; and SENTI-301A, an off-the-shelf CAR-NK cell therapy for the treatment of solid tumors and hepatocellular carcinoma. In addition, it develops the tumor-associated antigen and protective antigen paired discovery platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. Further, its pipeline includes preclinical programs, which comprise a solid tumor cell therapy program; and partnered programs related to gene therapies for tissue-directed targets, as well as partnered programs related to cell therapies for regenerative medicines. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 34, "companyOfficers": [{"maxAge": 1, "name": "Dr. Timothy K. Lu M.D., Ph.D.", "age": 43, "title": "Co-Founder, CEO & Director", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 630788, "exercisedValue": 0, "unexercisedValue": 261713}, {"maxAge": 1, "name": "Dr. Kanya  Rajangam M.D., Ph.D.", "age": 51, "title": "President, Head of Research & Development and Chief Medical Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 794047, "exercisedValue": 0, "unexercisedValue": 244533}, {"maxAge": 1, "name": "Dr. James J. Collins Ph.D.", "age": 58, "title": "Scientific Co-Founder, Chairperson of Scientific Advisory Board & Independent Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 43875, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Wilson  Wong Ph.D.", "title": "Scientific Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jay  Cross", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Faraz  Siddiqui", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert H. Cutler J.D.", "age": 56, "title": "Senior VP & Head of Legal Affairs", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas P. Chung", "title": "Vice President of Strategic Finance & Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Dee Olomajeye Dragon", "title": "VP of People & Culture Strategy & Head of Administrative Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.18, "open": 2.1, "dayLow": 2.07, "dayHigh": 2.18, "regularMarketPreviousClose": 2.18, "regularMarketOpen": 2.1, "regularMarketDayLow": 2.07, "regularMarketDayHigh": 2.18, "payoutRatio": 0.0, "beta": 2.05, "forwardPE": -2.8666668, "volume": 133029, "regularMarketVolume": 133029, "averageVolume": 193868, "averageVolume10days": 505530, "averageDailyVolume10Day": 505530, "bid": 1.57, "ask": 2.73, "bidSize": 2, "askSize": 2, "marketCap": 56244444, "fiftyTwoWeekLow": 1.26, "fiftyTwoWeekHigh": 16.94, "allTimeHigh": 105.4, "allTimeLow": 1.26, "fiftyDayAverage": 1.5521, "twoHundredDayAverage": 2.81998, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 65883444, "profitMargins": 0.0, "floatShares": 9575682, "sharesOutstanding": 26160206, "sharesShort": 228115, "sharesShortPriorMonth": 240943, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.0087, "heldPercentInsiders": 0.57035, "heldPercentInstitutions": 0.2576, "shortRatio": 1.71, "shortPercentOfFloat": 0.0088, "impliedSharesOutstanding": 26160206, "bookValue": 0.942, "priceToBook": 2.2823782, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -60843000, "trailingEps": -8.52, "forwardEps": -0.75, "lastSplitFactor": "1:10", "lastSplitDate": 1721260800, "enterpriseToEbitda": -1.232, "52WeekChange": -0.048672557, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 2.15, "targetHighPrice": 15.0, "targetLowPrice": 12.0, "targetMeanPrice": 13.5, "targetMedianPrice": 13.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 21672000, "totalCashPerShare": 0.828, "ebitda": -53459000, "totalDebt": 31311000, "quickRatio": 2.54, "currentRatio": 3.256, "debtToEquity": 127.012, "returnOnAssets": -0.4598, "returnOnEquity": -1.69538, "grossProfits": -35737000, "freeCashflow": -8293750, "operatingCashflow": -48493000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SNTI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Senti Biosciences, Inc.", "postMarketChangePercent": -1.86047, "postMarketPrice": 2.11, "postMarketChange": -0.0400002, "regularMarketChange": -0.03, "regularMarketDayRange": "2.07 - 2.18", "earningsTimestampStart": 1755115260, "earningsTimestampEnd": 1755547260, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -8.52, "epsForward": -0.75, "epsCurrentYear": -2.38, "priceEpsCurrentYear": -0.9033613, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1622035800000, "shortName": "Senti Biosciences, Inc.", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 193868, "fiftyTwoWeekLowChange": 0.8900001, "fiftyTwoWeekLowChangePercent": 0.7063493, "fiftyTwoWeekRange": "1.26 - 16.94", "fiftyTwoWeekHighChange": -14.790001, "fiftyTwoWeekHighChangePercent": -0.8730815, "fiftyTwoWeekChangePercent": -4.8672557, "marketState": "CLOSED", "fiftyDayAverageChange": 0.59790015, "fiftyDayAverageChangePercent": 0.38522014, "twoHundredDayAverageChange": -0.6699798, "twoHundredDayAverageChangePercent": -0.23758319, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -1.37615, "regularMarketPrice": 2.15, "corporateActions": [], "postMarketTime": 1760740882, "regularMarketTime": 1760731200, "exchange": "NCM", "messageBoardId": "finmb_538838857", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Senti Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]